Moreover, this hypoglycemia/insulin-induced copeptin and glucagon elevation is notably attenuated in individuals with type 1 diabetes (T1D) compared to non-diabetic BMI and age-matched controls [4]. This evidence concerns the gene AVP and type 1 diabetes mellitus.